Pub Date : 2025-08-01DOI: 10.1016/j.mucimm.2025.05.006
Liyen Loh , David J. Orlicky , Andrea Spengler , Joanne Domenico , Jared Klarquist , Cassandra Levens , Sofia Celli , Jennifer M. Kofonow , Charles E. Robertson , Olivier Lantz , Francois Legoux , Daniel N. Frank , Jennifer Matsuda , Paul J. Norman , Kristine A. Kuhn , Joseph Onyiah , Laurent Gapin
IL-17-producing lymphocytes are involved in both tissue repair and the propagation of inflammation, with their effects highly context-dependent. Mucosal-Associated-Invariant-T-cells (MAIT), a subset of innate-like T cells with features of both Th1 and Th17 lineages, are increasingly recognized for their roles in mucosal immunity. Here, we identified the Collaborative-Cross CC011/Unc strain, which spontaneously develops chronic colitis, as being enriched for MAIT cells. This expansion coincides with an age-related loss of intestinal barrier permeability and colonic inflammation. Microbiota from CC011 mice activated MAIT cells in an MR1-dependent manner and selectively promoted the accumulation of MAIT17 cells in peripheral tissues. Single-cell transcriptomic analyses revealed colon MAIT cells from colitic CC011 mice expressed a pathogenic Th17-like signature, characterized by IL-1 and IL-23 signaling, IL-17A and IFNγ co-expression, and upregulation of IL-23R, features that correlated with inflammatory Ly6Chi monocyte abundance. Genetic deletion of Traj33, essential for MAIT development, significantly reduced colonic inflammation in this model. These findings demonstrate that MAIT cells integrate microbial and cytokine cues to adopt a pathogenic effector phenotype that exacerbates chronic intestinal inflammation.
{"title":"MAIT cells exacerbate colonic inflammation in a genetically diverse murine model of spontaneous colitis","authors":"Liyen Loh , David J. Orlicky , Andrea Spengler , Joanne Domenico , Jared Klarquist , Cassandra Levens , Sofia Celli , Jennifer M. Kofonow , Charles E. Robertson , Olivier Lantz , Francois Legoux , Daniel N. Frank , Jennifer Matsuda , Paul J. Norman , Kristine A. Kuhn , Joseph Onyiah , Laurent Gapin","doi":"10.1016/j.mucimm.2025.05.006","DOIUrl":"10.1016/j.mucimm.2025.05.006","url":null,"abstract":"<div><div>IL-17-producing lymphocytes are involved in both tissue repair and the propagation of inflammation, with their effects highly context-dependent. Mucosal-Associated-Invariant-T-cells (MAIT), a subset of innate-like T cells with features of both Th1 and Th17 lineages, are increasingly recognized for their roles in mucosal immunity. Here, we identified the Collaborative-Cross CC011/Unc strain, which spontaneously develops chronic colitis, as being enriched for MAIT cells. This expansion coincides with an age-related loss of intestinal barrier permeability and colonic inflammation. Microbiota from CC011 mice activated MAIT cells in an MR1-dependent manner and selectively promoted the accumulation of MAIT17 cells in peripheral tissues. Single-cell transcriptomic analyses revealed colon MAIT cells from colitic CC011 mice expressed a pathogenic Th17-like signature, characterized by IL-1 and IL-23 signaling, IL-17A and IFNγ co-expression, and upregulation of IL-23R, features that correlated with inflammatory Ly6C<sup>hi</sup> monocyte abundance. Genetic deletion of <em>Traj33</em>, essential for MAIT development, significantly reduced colonic inflammation in this model. These findings demonstrate that MAIT cells integrate microbial and cytokine cues to adopt a pathogenic effector phenotype that exacerbates chronic intestinal inflammation.</div></div>","PeriodicalId":18877,"journal":{"name":"Mucosal Immunology","volume":"18 4","pages":"Pages 958-972"},"PeriodicalIF":7.6,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144160548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-01DOI: 10.1016/j.mucimm.2025.05.003
Yixuan D. Zhou , Macy R. Komnick , Fabiola Sepulveda , Grace Liu , Elida Nieves-Ortiz , Kelsey Meador , Ornella Ndatabaye , Aliia Fatkhullina , Asha Bozicevich , Braden Juengel , Natalie J. Wu-Woods , Paulina M. Naydenkov , Johnathan Kent , Nathaniel Christiansen , Maria Lucia Madariaga , Piotr Witkowski , Rustem F. Ismagilov , Daria Esterházy
The REG/Reg gene locus encodes a conserved family of potent antimicrobial but also pancreatitis-associated proteins. Here we investigated whether REG/Reg family members differ in their baseline expression levels and abilities to be regulated in the pancreas and gut upon perturbations. We found, in humans and mice, the pancreas and gut differed in REG/Reg isoform levels and preferences, with the duodenum most resembling the pancreas. Pancreatic acinar cells and intestinal enterocytes were the dominant REG producers. Intestinal symbiotic microbes regulated the expression of the same, select Reg members in gut and pancreas. These Reg members had the most STAT3-binding sites close to the transcription start sites and were partially IL-22 dependent. We thus categorized them as “inducible” and others as “constitutive”. Indeed, in pancreatic ductal adenocarcinoma and pancreatitis models, only inducible Reg members were upregulated in the pancreas. While intestinal Reg expression remained unchanged upon pancreatic perturbation, pancreatitis altered the microbial composition of the duodenum and feces shortly after disease onset. Our study reveals differential usage and regulation of REG/Reg isoforms as a mechanism for tissue-specific innate immunity, highlights the intimate connection of pancreas and duodenum, and implies a gut-to-pancreas communication axis resulting in a coordinated Reg response.
{"title":"Inducible, but not constitutive, pancreatic REG/Reg isoforms are regulated by intestinal microbiota and pancreatic diseases","authors":"Yixuan D. Zhou , Macy R. Komnick , Fabiola Sepulveda , Grace Liu , Elida Nieves-Ortiz , Kelsey Meador , Ornella Ndatabaye , Aliia Fatkhullina , Asha Bozicevich , Braden Juengel , Natalie J. Wu-Woods , Paulina M. Naydenkov , Johnathan Kent , Nathaniel Christiansen , Maria Lucia Madariaga , Piotr Witkowski , Rustem F. Ismagilov , Daria Esterházy","doi":"10.1016/j.mucimm.2025.05.003","DOIUrl":"10.1016/j.mucimm.2025.05.003","url":null,"abstract":"<div><div>The <em>REG</em>/<em>Reg</em> gene locus encodes a conserved family of potent antimicrobial but also pancreatitis-associated proteins. Here we investigated whether <em>REG/Reg</em> family members differ in their baseline expression levels and abilities to be regulated in the pancreas and gut upon perturbations. We found, in humans and mice, the pancreas and gut differed in <em>REG</em>/<em>Reg</em> isoform levels and preferences, with the duodenum most resembling the pancreas. Pancreatic acinar cells and intestinal enterocytes were the dominant REG producers. Intestinal symbiotic microbes regulated the expression of the same, select <em>Reg</em> members in gut and pancreas. These <em>Reg</em> members had the most STAT3-binding sites close to the transcription start sites and were partially IL-22 dependent. We thus categorized them as “inducible” and others as “constitutive”. Indeed, in pancreatic ductal adenocarcinoma and pancreatitis models, only inducible <em>Reg</em> members were upregulated in the pancreas. While intestinal <em>Reg</em> expression remained unchanged upon pancreatic perturbation, pancreatitis altered the microbial composition of the duodenum and feces shortly after disease onset. Our study reveals differential usage and regulation of <em>REG</em>/<em>Reg</em> isoforms as a mechanism for tissue-specific innate immunity, highlights the intimate connection of pancreas and duodenum, and implies a gut-to-pancreas communication axis resulting in a coordinated <em>Reg</em> response.</div></div>","PeriodicalId":18877,"journal":{"name":"Mucosal Immunology","volume":"18 4","pages":"Pages 918-936"},"PeriodicalIF":7.6,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144120342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-01DOI: 10.1016/j.mucimm.2025.04.007
Alexander D. Ethridge , Kazuma Yagi , Llilian Arzola Martínez , Andrew J. Rasky , Susan B. Morris , Nicole R. Falkowski , Gary B. Huffnagle , Nicholas W. Lukacs
Severe respiratory syncytial virus (RSV) infection during infancy is associated with a 2 to 4-fold increased risk for the development of wheezing and asthma. Recent studies have implicated microbiome changes, either within the lung or gut, during early life can also affect the development of pulmonary disease. Our studies demonstrate long-term gastrointestinal and lung microbiome changes following early life (EL) RSV infection. To determine the respective roles of ELRSV infection and the gut microbiome, we performed germ-free neonatal infection and microbiome colonization using a microbiome from an uninfected animal followed by cockroach allergen (CRA)-induced asthma 4 weeks later. Germ-free animals with ELRSV infection displayed increased airway disease that was diminished by microbiome colonization, including airway hyperreactivity (AHR), mucus, and eosinophil infiltration. To address the role of virus induced gastrointestinal microbiome alterations, we utilized GF mice conventionalized with RSV-associated or naive microbiomes followed by CRA-induced disease. Transfer of neonatal microbiome taken during acute RSV infection did not alter the allergic response to CRA. However, the transfer of a naive adult microbiome conferred protection from enhanced AHR in response to CRA whereas an RSV associated microbiome did not. Taken together, our data indicate that microbiome alteration and early life RSV infection both contribute to allergic predisposition.
{"title":"RSV infection in neonatal mice and gastrointestinal microbiome alteration contribute to allergic predisposition","authors":"Alexander D. Ethridge , Kazuma Yagi , Llilian Arzola Martínez , Andrew J. Rasky , Susan B. Morris , Nicole R. Falkowski , Gary B. Huffnagle , Nicholas W. Lukacs","doi":"10.1016/j.mucimm.2025.04.007","DOIUrl":"10.1016/j.mucimm.2025.04.007","url":null,"abstract":"<div><div>Severe respiratory syncytial virus (RSV) infection during infancy is associated with a 2 to 4-fold increased risk for the development of wheezing and asthma. Recent studies have implicated microbiome changes, either within the lung or gut, during early life can also affect the development of pulmonary disease. Our studies demonstrate long-term gastrointestinal and lung microbiome changes following early life (EL) RSV infection. To determine the respective roles of ELRSV infection and the gut microbiome, we performed germ-free neonatal infection and microbiome colonization using a microbiome from an uninfected animal followed by cockroach allergen (CRA)-induced asthma 4 weeks later. Germ-free animals with ELRSV infection displayed increased airway disease that was diminished by microbiome colonization, including airway hyperreactivity (AHR), mucus, and eosinophil infiltration. To address the role of virus induced gastrointestinal microbiome alterations, we utilized GF mice conventionalized with RSV-associated or naive microbiomes followed by CRA-induced disease. Transfer of neonatal microbiome taken during acute RSV infection did not alter the allergic response to CRA. However, the transfer of a naive adult microbiome conferred protection from enhanced AHR in response to CRA whereas an RSV associated microbiome did not. Taken together, our data indicate that microbiome alteration and early life RSV infection both contribute to allergic predisposition.</div></div>","PeriodicalId":18877,"journal":{"name":"Mucosal Immunology","volume":"18 4","pages":"Pages 874-886"},"PeriodicalIF":7.6,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143993945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-01DOI: 10.1016/j.mucimm.2025.04.003
Mihovil Joja , Erica T. Grant , Mahesh S. Desai
The colonic mucus layer acts as a physicochemical barrier to pathogen invasion and as a habitat for mucus-associated microbes. This mucosal microbiome plays a crucial role in moderating mucus production, maintaining barrier integrity, and shaping the host immune response. However, unchecked mucin foraging may render the host vulnerable to disease. To better understand these dynamics in the mucus layer, it is essential to advance fundamental knowledge on how commensals bind to and utilize mucin as well as their interactions with both the host and their microbial neighbors. We present an overview of approaches for surveying mucus-associated bacteria and assessing their mucin-utilizing capacity, alongside a discussion of the limitations of existing methods. Additionally, we highlight how diet and host secretory immunoglobulin A interact with the mucosal bacterial community in the colon. Insights into this subset of the microbial community can guide therapeutic strategies to optimally support and modulate mucosal barrier integrity.
{"title":"Living on the edge: Mucus-associated microbes in the colon","authors":"Mihovil Joja , Erica T. Grant , Mahesh S. Desai","doi":"10.1016/j.mucimm.2025.04.003","DOIUrl":"10.1016/j.mucimm.2025.04.003","url":null,"abstract":"<div><div>The colonic mucus layer acts as a physicochemical barrier to pathogen invasion and as a habitat for mucus-associated microbes. This mucosal microbiome plays a crucial role in moderating mucus production, maintaining barrier integrity, and shaping the host immune response. However, unchecked mucin foraging may render the host vulnerable to disease. To better understand these dynamics in the mucus layer, it is essential to advance fundamental knowledge on how commensals bind to and utilize mucin as well as their interactions with both the host and their microbial neighbors. We present an overview of approaches for surveying mucus-associated bacteria and assessing their mucin-utilizing capacity, alongside a discussion of the limitations of existing methods. Additionally, we highlight how diet and host secretory immunoglobulin A interact with the mucosal bacterial community in the colon. Insights into this subset of the microbial community can guide therapeutic strategies to optimally support and modulate mucosal barrier integrity.</div></div>","PeriodicalId":18877,"journal":{"name":"Mucosal Immunology","volume":"18 4","pages":"Pages 770-781"},"PeriodicalIF":7.6,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144028688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-01DOI: 10.1016/j.mucimm.2025.06.003
Amanpreet Singh Chawla , Maud Vandereyken , Maykel Arias , Llipsy Santiago , Dina Dikovskaya , Chi Nguyen , Neema Skariah , Nicolas Wenner , Natasha B. Golovchenko , Sarah J. Thomson , Edna Ondari , Marcela Garzón-Tituaña , Christopher J. Anderson , Megan Bergkessel , Jay C.D. Hinton , Karen L. Edelblum , Julian Pardo , Mahima Swamy
{"title":"Corrigendum to “Distinct cell death pathways induced by granzymes collectively protect against intestinal Salmonella infection” [Mucosal. Immun. 17 (2024) 1242–1255]","authors":"Amanpreet Singh Chawla , Maud Vandereyken , Maykel Arias , Llipsy Santiago , Dina Dikovskaya , Chi Nguyen , Neema Skariah , Nicolas Wenner , Natasha B. Golovchenko , Sarah J. Thomson , Edna Ondari , Marcela Garzón-Tituaña , Christopher J. Anderson , Megan Bergkessel , Jay C.D. Hinton , Karen L. Edelblum , Julian Pardo , Mahima Swamy","doi":"10.1016/j.mucimm.2025.06.003","DOIUrl":"10.1016/j.mucimm.2025.06.003","url":null,"abstract":"","PeriodicalId":18877,"journal":{"name":"Mucosal Immunology","volume":"18 4","pages":"Page 1003"},"PeriodicalIF":7.6,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144771548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-01DOI: 10.1016/j.mucimm.2025.03.007
Yeganeh Yousefi , Zarin Haider , Jensine A. Grondin , Huaqing Wang , Sabah Haq , Suhrid Banskota , Tyler Seto , Michael Surette , Waliul I. Khan
Alterations in goblet cell biology constitute one of the most effective host responses against enteric parasites. In the gastrointestinal (GI) tract, millions of bacteria influence these goblet cell responses by binding to pattern recognition receptors such as toll-like receptors (TLRs). Studies suggest that the gut microbiota also interacts bidirectionally with enteric parasites, including Trichuris muris. Here, we study the roles of T. muris-altered microbiota and the TLR2-SPDEF axis in parasitic host defense. In acute T. muris infection, we observed altered gut microbiota composition, which, when transferred to germ-free mice, resulted in increased goblet cell numbers, Th2 cytokines and Muc2 expression, as well as increased Tlr2. Further, antibiotic (ABX)-treated TLR2-/- mice, despite having received the same T. muris-altered microbiota, displayed diminished Th2 response, Muc2 expression, and, intriguingly, diminished SPDEF expression compared to wildtype counterparts. When infected with T. muris, SPDEF-/- mice exhibited a reduced Th2 response and altered microbial composition compared to SPDEF+/+, particularly on day 14 post-infection, and this microbiota was sufficient to alter host goblet cell response when transferred to ABX-treated mice. Taken together, our findings suggest the TLR2-SPDEF axis, via T. muris-induced microbial changes, is an important regulator of goblet cell function and host’s parasitic defense.
{"title":"Gut microbiota regulates intestinal goblet cell response and mucin production by influencing the TLR2-SPDEF axis in an enteric parasitic infection","authors":"Yeganeh Yousefi , Zarin Haider , Jensine A. Grondin , Huaqing Wang , Sabah Haq , Suhrid Banskota , Tyler Seto , Michael Surette , Waliul I. Khan","doi":"10.1016/j.mucimm.2025.03.007","DOIUrl":"10.1016/j.mucimm.2025.03.007","url":null,"abstract":"<div><div>Alterations in goblet cell biology constitute one of the most effective host responses against enteric parasites. In the gastrointestinal (GI) tract, millions of bacteria influence these goblet cell responses by binding to pattern recognition receptors such as toll-like receptors (TLRs). Studies suggest that the gut microbiota also interacts bidirectionally with enteric parasites, including <em>Trichuris muris</em>. Here, we study the roles of <em>T. muris</em>-altered microbiota and the TLR2-SPDEF axis in parasitic host defense. In acute <em>T. muris</em> infection, we observed altered gut microbiota composition, which, when transferred to germ-free mice, resulted in increased goblet cell numbers, Th2 cytokines and <em>Muc2</em> expression, as well as increased <em>Tlr2</em>. Further, antibiotic (ABX)-treated TLR2<sup>-/-</sup> mice, despite having received the same <em>T. muris</em>-altered microbiota, displayed diminished Th2 response, <em>Muc2</em> expression, and, intriguingly, diminished SPDEF expression compared to wildtype counterparts. When infected with <em>T. muris</em>, <em>SPDEF<sup>-/-</sup></em> mice exhibited a reduced Th2 response and altered microbial composition compared to <em>SPDEF<sup>+/+</sup></em>, particularly on day 14 post-infection, and this microbiota was sufficient to alter host goblet cell response when transferred to ABX-treated mice. Taken together, our findings suggest the TLR2-SPDEF axis, via <em>T. muris</em>-induced microbial changes, is an important regulator of goblet cell function and host’s parasitic defense.</div></div>","PeriodicalId":18877,"journal":{"name":"Mucosal Immunology","volume":"18 4","pages":"Pages 810-824"},"PeriodicalIF":7.6,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143753442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Intranasal vaccines potentially offer superior protection against viral infections compared with injectable vaccines. The immunogenicity of intranasal vaccines including adenovirus vector (AdV), has room for improvement, while few options are available for safe execution. In this study, we demonstrate that modifying a basic parameter of vaccine formulation, i.e., osmolarity, can significantly enhance the immunogenicity of intranasal vaccines. Addition of glycerol to AdV intranasal vaccine solutions, unlike other viscous additives, enhanced systemic and mucosal antibodies as well as resident memory T cells in the nasal tissues, which could protect nasal tissue and the lungs against influenza virus. While viscous glycerol could not prolong intranasal retention of solutes, it promoted AdV infection of nasal epithelial cells by facilitating AdV access to the nasal epithelial cell. The enhanced immunogenicity was induced by the hypertonicity of vaccine preparations and sodium chloride, glucose, and mannitol demonstrated the capacity to enhance immunogenicity. Moreover, hypertonic glycerol enhanced the immunogenicity of adjuvanted subunit intranasal vaccines, but not subunit vaccines without adjuvant or injectable vaccines. Overall, the delivery of intranasal vaccines to nasal epithelial cells could be improved through a simple approach, potentially resulting in stronger immunogenicity for certain vaccines.
与注射疫苗相比,鼻内疫苗有可能提供更好的病毒感染保护。包括腺病毒载体(AdV)在内的鼻内疫苗的免疫原性还有待提高,而安全接种的方案却不多。在这项研究中,我们证明了改变疫苗配方的一个基本参数,即渗透压,可以显著提高鼻内疫苗的免疫原性。与其他粘性添加剂不同,在 AdV 鼻内疫苗溶液中添加甘油可增强全身和粘膜抗体以及鼻腔组织中的常驻记忆 T 细胞,从而保护鼻腔组织和肺部免受流感病毒的侵袭。虽然粘性甘油不能延长溶质的鼻内滞留时间,但它能促进 AdV 进入鼻上皮细胞,从而促进 AdV 感染鼻上皮细胞。疫苗制剂的高渗性诱导了免疫原性的增强,氯化钠、葡萄糖和甘露醇都表现出了增强免疫原性的能力。此外,高渗甘油能增强佐剂亚单位鼻内疫苗的免疫原性,但不能增强无佐剂亚单位疫苗或注射疫苗的免疫原性。总之,鼻内疫苗向鼻上皮细胞的输送可以通过一种简单的方法得到改善,从而有可能增强某些疫苗的免疫原性。
{"title":"Hypertonic intranasal vaccines gain nasal epithelia access to exert strong immunogenicity","authors":"Soichiro Hashimoto , Toshiro Hirai , Koki Ueda , Mako Kakihara , Nagisa Tokunoh , Chikako Ono , Yoshiharu Matsuura , Kazuo Takayama , Yasuo Yoshioka","doi":"10.1016/j.mucimm.2025.03.006","DOIUrl":"10.1016/j.mucimm.2025.03.006","url":null,"abstract":"<div><div>Intranasal vaccines potentially offer superior protection against viral infections compared with injectable vaccines. The immunogenicity of intranasal vaccines including adenovirus vector (AdV), has room for improvement, while few options are available for safe execution. In this study, we demonstrate that modifying a basic parameter of vaccine formulation, i.e., osmolarity, can significantly enhance the immunogenicity of intranasal vaccines. Addition of glycerol to AdV intranasal vaccine solutions, unlike other viscous additives, enhanced systemic and mucosal antibodies as well as resident memory T cells in the nasal tissues, which could protect nasal tissue and the lungs against influenza virus. While viscous glycerol could not prolong intranasal retention of solutes, it promoted AdV infection of nasal epithelial cells by facilitating AdV access to the nasal epithelial cell. The enhanced immunogenicity was induced by the hypertonicity of vaccine preparations and sodium chloride, glucose, and mannitol demonstrated the capacity to enhance immunogenicity. Moreover, hypertonic glycerol enhanced the immunogenicity of adjuvanted subunit intranasal vaccines, but not subunit vaccines without adjuvant or injectable vaccines. Overall, the delivery of intranasal vaccines to nasal epithelial cells could be improved through a simple approach, potentially resulting in stronger immunogenicity for certain vaccines.</div></div>","PeriodicalId":18877,"journal":{"name":"Mucosal Immunology","volume":"18 4","pages":"Pages 793-809"},"PeriodicalIF":7.6,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143780563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-01DOI: 10.1016/j.mucimm.2025.04.008
Rohin Chakraborty, Julia Chronopoulos, Rui Sun, Arina Morozan, Sydney Joy, Maziar Divangahi, Anne-Marie Lauzon, James G. Martin
Influenza A virus (IAV) infections trigger asthma attacks and cause airway hyperresponsiveness (AHR) in murine models. However, the mechanism by which AHR is induced remains to be fully elucidated. Here, we show that targeting the interleukin (IL)–33 suppression of tumorigenicity 2 (ST2) receptor complex with an anti-ST2 antibody during acute IAV infection of C57BL/6 mice reduced AHR, without affecting expansion of ILC2s and independently of IL-13. Among the lung inflammatory cells, the anti-ST2 antibody selectively reduced the monocyte-derived macrophages (MMs). Furthermore, AHR was reduced in C–C chemokine receptor 2 (CCR2)-knockout mice that have deficient MM recruitment. Depletion of MMs achieved by anti-Ly6C antibody administration also reduced AHR. The treatment of airway smooth muscle (ASM) with conditioned medium from IL-33-treated human THP-1-derived macrophages enhanced potassium chloride-induced ASM contraction. These findings suggest that MMs contribute to acute AHR following IAV infection in an IL-33-dependent manner, but independent of the ILC2/IL-13 axis. Additionally, IL-33 stimulates the release of macrophage-derived mediators that enhance airway smooth muscle contraction, offering a potential mechanistic basis for IAV-induced AHR.
{"title":"Anti-ST2 antibody reduces airway hyperresponsiveness mediated by monocyte-derived macrophages during influenza A infection","authors":"Rohin Chakraborty, Julia Chronopoulos, Rui Sun, Arina Morozan, Sydney Joy, Maziar Divangahi, Anne-Marie Lauzon, James G. Martin","doi":"10.1016/j.mucimm.2025.04.008","DOIUrl":"10.1016/j.mucimm.2025.04.008","url":null,"abstract":"<div><div>Influenza A virus (IAV) infections trigger asthma attacks and cause airway hyperresponsiveness (AHR) in murine models. However, the mechanism by which AHR is induced remains to be fully elucidated. Here, we show that targeting the interleukin (IL)–33 suppression of tumorigenicity 2 (ST2) receptor complex with an anti-ST2 antibody during acute IAV infection of C57BL/6 mice reduced AHR, without affecting expansion of ILC2s and independently of IL-13. Among the lung inflammatory cells, the anti-ST2 antibody selectively reduced the monocyte-derived macrophages (MMs). Furthermore, AHR was reduced in C–C chemokine receptor 2 (CCR2)-knockout mice that have deficient MM recruitment. Depletion of MMs achieved by anti-Ly6C antibody administration also reduced AHR. The treatment of airway smooth muscle (ASM) with conditioned medium from IL-33-treated human THP-1-derived macrophages enhanced potassium chloride-induced ASM contraction. These findings suggest that MMs contribute to acute AHR following IAV infection in an IL-33-dependent manner, but independent of the ILC2/IL-13 axis. Additionally, IL-33 stimulates the release of macrophage-derived mediators that enhance airway smooth muscle contraction, offering a potential mechanistic basis for IAV-induced AHR.</div></div>","PeriodicalId":18877,"journal":{"name":"Mucosal Immunology","volume":"18 4","pages":"Pages 887-898"},"PeriodicalIF":7.6,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144012090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-01DOI: 10.1016/j.mucimm.2025.04.002
Vancheswaran Gopalakrishnan , Chanchal Kumar , Ida Robertsen , Christopher Morehouse , Ben Sparklin , Shameer Khader , Ian Henry , Line Kristin Johnson , Jens K. Hertel , Hege Christensen , Rune Sandbu , Peter J. Greasley , Bret R. Sellman , Anders Åsberg , Shalini Andersson , Rasmus Jansson Löfmark , Jøran Hjelmesæth , Cecilia Karlsson , Taylor S. Cohen
Roux-en-Y gastric bypass (GBP) surgery is an effective treatment for reducing body weight and correcting metabolic dysfunction in individuals with severe obesity. Herein, we characterize the differences between very low energy diet (VLED) and GBP induced weight loss by multi-omic analyses of microbiome and host features in a non-randomized, controlled, single-center study. Eighty-eight participants with severe obesity were recruited into two arms – GBP versus VLED with matching weight loss for 6 weeks and 2-years of follow-up. A dramatic shift in the distribution of gut microbial taxa and their functional capacity was seen in the GBP group at Week 2 after surgery and was sustained through 2 years. Multi-omic analyses were performed after 6 weeks of matching weight loss between the GBP and VLED groups, which pointed to microbiome derived metabolites such as indoxyl sulphate as characterizing the GBP group. We also identified an inverse association between Streptococcus parasanguinis (an oral commensal) and plasma levels of tryptophan and tyrosine. These data have important implications, as they reveal a significant robust restructuring of the microbiome away from a baseline dysbiotic state in the GBP group. Furthermore, multi-omics modelling points to potentially novel mechanistic insights at the intersection of the microbiome and host.
{"title":"A multi-omics microbiome signature is associated with the benefits of gastric bypass surgery and is differentiated from diet induced weight loss through 2 years of follow-up","authors":"Vancheswaran Gopalakrishnan , Chanchal Kumar , Ida Robertsen , Christopher Morehouse , Ben Sparklin , Shameer Khader , Ian Henry , Line Kristin Johnson , Jens K. Hertel , Hege Christensen , Rune Sandbu , Peter J. Greasley , Bret R. Sellman , Anders Åsberg , Shalini Andersson , Rasmus Jansson Löfmark , Jøran Hjelmesæth , Cecilia Karlsson , Taylor S. Cohen","doi":"10.1016/j.mucimm.2025.04.002","DOIUrl":"10.1016/j.mucimm.2025.04.002","url":null,"abstract":"<div><div>Roux-en-Y gastric bypass (GBP) surgery is an effective treatment for reducing body weight and correcting metabolic dysfunction in individuals with severe obesity. Herein, we characterize the differences between very low energy diet (VLED) and GBP induced weight loss by multi-omic analyses of microbiome and host features in a non-randomized, controlled, single-center study. Eighty-eight participants with severe obesity were recruited into two arms – GBP versus VLED with matching weight loss for 6 weeks and 2-years of follow-up. A dramatic shift in the distribution of gut microbial taxa and their functional capacity was seen in the GBP group at Week 2 after surgery and was sustained through 2 years. Multi-omic analyses were performed after 6 weeks of matching weight loss between the GBP and VLED groups, which pointed to microbiome derived metabolites such as indoxyl sulphate as characterizing the GBP group. We also identified an inverse association between <em>Streptococcus parasanguinis</em> (an oral commensal) and plasma levels of tryptophan and tyrosine. These data have important implications, as they reveal a significant robust restructuring of the microbiome away from a baseline dysbiotic state in the GBP group. Furthermore, multi-omics modelling points to potentially novel mechanistic insights at the intersection of the microbiome and host.</div></div>","PeriodicalId":18877,"journal":{"name":"Mucosal Immunology","volume":"18 4","pages":"Pages 825-835"},"PeriodicalIF":7.6,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143993830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-01DOI: 10.1016/j.mucimm.2025.04.009
Yen-Lin Lin, Chyung-Ru Wang
Dyslipidemia, characterized by altered lipid profiles, influences host immune responses against infections, including Mycobacterium tuberculosis (Mtb). While the effects of dyslipidemia on conventional T cell responses are well documented, its impact on group 1-CD1 restricted T cells, a distinct subset of lipid antigen-specific unconventional T cells, during Mtb infection remains unclear. In this study, we developed a double-transgenic mouse model expressing human group 1 CD1 (hCD1Tg) and mycolic acid (MA)-specific CD1b-restricted T cell receptor (DN1Tg) in a Rag-deficient and low-density lipoprotein receptor-deficient background to investigate how diet-induced dyslipidemia affects the functionality of MA-specific T cells and their role in anti-Mtb immunity. We found that diet-induced dyslipidemia led to increased IFN-γ production by MA-specific T cells, which promoted mycobacterial clearance in vitro. Mechanistically, this enhanced IFN-γ production was associated with increased TCR signaling and enhanced glycolysis in DN1 T cells, rather than changes in antigen presentation by dendritic cells. However, dyslipidemia also increased apoptosis in DN1 T cells, which may have impaired their ability to control mycobacterial infection in vivo, resulting in reduced bacterial clearance. These findings highlight a complex interplay between diet-induced dyslipidemia and lipid antigen-specific T-cell responses in Mtb infection, providing insights for potential therapeutic strategies to mitigate dyslipidemia-induced changes in T-cell functions.
{"title":"Diet-induced dyslipidemia enhances IFN-γ production in mycolic acid-specific T cells and affects mycobacterial control","authors":"Yen-Lin Lin, Chyung-Ru Wang","doi":"10.1016/j.mucimm.2025.04.009","DOIUrl":"10.1016/j.mucimm.2025.04.009","url":null,"abstract":"<div><div>Dyslipidemia, characterized by altered lipid profiles, influences host immune responses against infections, including <em>Mycobacterium tuberculosis</em> (Mtb). While the effects of dyslipidemia on conventional T cell responses are well documented, its impact on group 1-CD1 restricted T cells, a distinct subset of lipid antigen-specific unconventional T cells, during Mtb infection remains unclear. In this study, we developed a double-transgenic mouse model expressing human group 1 CD1 (hCD1Tg) and mycolic acid (MA)-specific CD1b-restricted T cell receptor (DN1Tg) in a Rag-deficient and low-density lipoprotein receptor-deficient background to investigate how diet-induced dyslipidemia affects the functionality of MA-specific T cells and their role in anti-Mtb immunity. We found that diet-induced dyslipidemia led to increased IFN-γ production by MA-specific T cells, which promoted mycobacterial clearance <em>in vitro</em>. Mechanistically, this enhanced IFN-γ production was associated with increased TCR signaling and enhanced glycolysis in DN1 T cells, rather than changes in antigen presentation by dendritic cells. However, dyslipidemia also increased apoptosis in DN1 T cells, which may have impaired their ability to control mycobacterial infection <em>in vivo</em>, resulting in reduced bacterial clearance. These findings highlight a complex interplay between diet-induced dyslipidemia and lipid antigen-specific T-cell responses in Mtb infection, providing insights for potential therapeutic strategies to mitigate dyslipidemia-induced changes in T-cell functions.</div></div>","PeriodicalId":18877,"journal":{"name":"Mucosal Immunology","volume":"18 4","pages":"Pages 899-910"},"PeriodicalIF":7.6,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144003450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}